These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8093103)

  • 21. Inhibition of monoamine oxidase by clorgyline analogues.
    O'Brien EM; Tipton KF; Meroni M; Dostert P
    J Neural Transm Suppl; 1994; 41():295-305. PubMed ID: 7931241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN; LeDuc BW; Khan AA
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):827-834. PubMed ID: 28185143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.
    Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat.
    Khandwala H; Loomis CW
    Pain; 1998 Jul; 77(1):87-95. PubMed ID: 9755023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors.
    Legoabe LJ; Petzer A; Petzer JP
    Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,4-Benzoquinone as a new inhibitor of monoamine oxidase.
    Naoi M; Nomura Y; Ishiki R; Suzuki H; Nagatsu T
    Neurosci Lett; 1987 Jun; 77(2):215-20. PubMed ID: 3601232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds.
    Naoi M; Nagatsu T
    J Neurochem; 1988 Apr; 50(4):1105-10. PubMed ID: 3346669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective inhibitors of monoamine oxidase. 2. Arylamide SAR.
    Harfenist M; Joyner CT; Mize PD; White HL
    J Med Chem; 1994 Jun; 37(13):2085-9. PubMed ID: 8027990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of brain mitochondrial monoamine oxidases by the endogenous compound 5-hydroxyoxindole.
    Crumeyrolle-Arias M; Tournaire MC; Cane A; Launay JM; Barritault D; Medvedev A
    Biochem Pharmacol; 2004 Mar; 67(5):977-9. PubMed ID: 15104251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
    Takao K; Saito T; Chikuda D; Sugita Y
    Chem Pharm Bull (Tokyo); 2016; 64(10):1499-1504. PubMed ID: 27725503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A screening system of prodrugs selective for MAO-A or MAO-B.
    Matsukawa M; Hirai T; Karita S; Akizawa T; Pan-Hou H; Yoshioka M; Goto G; Parvez H; Youdim MB
    Neurotoxicology; 2004 Jan; 25(1-2):293-302. PubMed ID: 14697904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of diethylnitrosamine on monoamine oxidase in rat liver.
    Obata T; Yamashita H; Egashira T; Yamanaka Y
    Jpn J Pharmacol; 1989 Jan; 49(1):151-3. PubMed ID: 2724679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of monoamine oxidase by selected phenylalkylcaffeine analogues.
    Petzer A; Grobler P; Bergh JJ; Petzer JP
    J Pharm Pharmacol; 2014 May; 66(5):677-87. PubMed ID: 24313346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors.
    Krueger MJ; Mazouz F; Ramsay RR; Milcent R; Singer TP
    Biochem Biophys Res Commun; 1995 Jan; 206(2):556-62. PubMed ID: 7826372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition and inactivation of monoamine oxidase by 3-amino-1-phenyl-prop-1-enes.
    Williams CH; Lawson J; Backwell FR
    Biochim Biophys Acta; 1992 Feb; 1119(2):111-7. PubMed ID: 1540641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.